AR002256A1 - ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE - Google Patents

ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE

Info

Publication number
AR002256A1
AR002256A1 ARP950100474A AR10047495A AR002256A1 AR 002256 A1 AR002256 A1 AR 002256A1 AR P950100474 A ARP950100474 A AR P950100474A AR 10047495 A AR10047495 A AR 10047495A AR 002256 A1 AR002256 A1 AR 002256A1
Authority
AR
Argentina
Prior art keywords
useful
inflammatory composition
water
otorilaringological
ophthalologic
Prior art date
Application number
ARP950100474A
Other languages
Spanish (es)
Inventor
Doron Friedman
Yaacov J Guy
Original Assignee
Pharmos Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmos Corp filed Critical Pharmos Corp
Priority to ARP950100474A priority Critical patent/AR002256A1/en
Publication of AR002256A1 publication Critical patent/AR002256A1/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Composición anti-inflamatoria, útil para uso oftálmico u otolaringólogico, particularmente nuevas composiciones de suministro de drogas esteroidalesinsolubles en agua, útiles para uso terapéutico. La invención provee además suspensiones acuosasinsolubles en agua útiles para uso terapéutico. Lainvención provee además suspensiones acuosas estables de drogas esteroidales insolubles en agua que tienen tamanos de partículas de l µm que permanecen endicho estado a fin de permitir lasuspensió n inmediata, cuando sea, incluso después de períodos de sedimentación prolongados.Anti-inflammatory composition, useful for ophthalmic or otolaryngological use, particularly new water-soluble steroidal drug delivery compositions, useful for therapeutic use. The invention further provides water-insoluble aqueous suspensions useful for therapeutic use. The invention further provides stable aqueous suspensions of water-insoluble steroidal drugs having particle sizes of 1 µm that remain in this state in order to allow immediate suspension, whenever, even after prolonged periods of sedimentation.

ARP950100474A 1995-12-06 1995-12-06 ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE AR002256A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ARP950100474A AR002256A1 (en) 1995-12-06 1995-12-06 ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ARP950100474A AR002256A1 (en) 1995-12-06 1995-12-06 ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE

Publications (1)

Publication Number Publication Date
AR002256A1 true AR002256A1 (en) 1998-03-11

Family

ID=37067347

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP950100474A AR002256A1 (en) 1995-12-06 1995-12-06 ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE

Country Status (1)

Country Link
AR (1) AR002256A1 (en)

Similar Documents

Publication Publication Date Title
BR9407958A (en) Composition for ophthalmic or otolaryngological anti-inflammatory use
ES2187201T3 (en) USE OF STEROLES AND STEROLESTERS TO NANOESCALA.
BR9711856A (en) Pharmacologically active agents stabilized with protein, methods for their preparation and methods for their use
BR9802509A (en) Use of a copolymer having a suffective or surfactant structure as a dispersing and / or grinding aid.
HRP20010463B1 (en) Controlled release galantamine composition
IL161290A0 (en) Stable composition comprising particles in a frozen aqueous matrix
AU2003304237A1 (en) Gel-stabilized nanoparticulate active agent compositions
BR9714015A (en) Pharmaceutical formulations for prolonged drug delivery
CA2345121A1 (en) Pharmaceutical composition for the treatment of acute disorders
AU2155199A (en) Microparticles for drug delivery across mucosa and the blood-brain barrier
HUP0203028A2 (en) Pharmaceutical formulation containing tolterodine and its use
NZ513032A (en) Non-irritating anti-microbial compostitions
BR0109091A (en) Sustained Release Ranolazine Formulations
PT707848E (en) SOLID PHARMACEUTICAL COMPOSITION COMPREHENDING AN EXCIPIENT CAPACITY TO CONNECT WATER
MY135119A (en) Stabilized oral suspension formulation
BR0210630A (en) Extended release supplier system
ES2231176T3 (en) USE OF BETA- (1,3) -NANOMETRIC GLANES HYDROSOLUBLES.
BR0014878A (en) Pharmaceutical composition containing cyclosonide for mucosal application
PT1189595E (en) Ophthalmic compositions in the form of aqueous oils
AU1368497A (en) New aqueous swellable compositions of guar gum and guar gum derivatives in oleophilic liquids and their use
AR002256A1 (en) ANTI-INFLAMMATORY COMPOSITION, USEFUL FOR OPHTHALOLOGIC AND OTORILARINGOLOGICAL USE
BR9811994A (en) Pharmaceutical suspension comprising nevirapine hemihydrate
EE05317B1 (en) Ethin 1 "Pharmaceutical Composition Containing Stradiol and Drospirenone for Use as a Contraceptive
BR0206960A (en) Oral pharmaceutical composition and use of a hydroxypropyl methylcellulose phthalate polymer
AU8387601A (en) Novel pharmaceutical composition for the topical application of water-insoluble and/or hardly water-soluble active agents

Legal Events

Date Code Title Description
FB Suspension of granting procedure